Aigh Capital Management LLC Pds Biotechnology Corp Transaction History

Aigh Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.05 - $6.68 $861,957 - $1.89 Million	-282,609 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$4.78 - $8.43 $121,531 - $214,332	-25,425 Reduced 8.25%	282,609 $1.75 Million
Q4 2021 Feb 10, 2022	SELL	$7.76 - $14.35 $3.61 Million - $6.68 Million	-465,526 Reduced 60.18%	308,034 $2.5 Million
Q3 2021 Nov 12, 2021	SELL	$9.33 - $17.08 $6.77 Million - $12.4 Million	-725,589 Reduced 48.4%	773,560 $11.5 Million
Q2 2021 Aug 12, 2021	BUY	$4.35 - $12.86 $6.52 Million - $19.3 Million	1,499,149 New	1,499,149 $18.8 Million

5.47M

155K

61.7K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $95.9M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.